Skip to content

Exploring the lmpact of Digital Therapy on the Ocular Growth of Amblyopic Eyes in children: A Real-World Retrospective Cohort Study

Exploring the lmpact of Digital Therapy on the Ocular Growth of Amblyopic Eyes in children: A Real-World Retrospective Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500109548
Enrollment
Unknown
Registered
2025-09-22
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amblyopia

Interventions

Digital Therapeutics Group:None
Traditional therapy group:None

Sponsors

The Zhongshan Ophthalmic Center,Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 12 Years

Inclusion criteria

Inclusion criteria: Digital Therapy Group Inclusion Criteria: 1. Diagnosis of amblyopia in one or both eyes; 2. Age between 3 ~ 12 years old; 3. Complete 90 days of digital therapy treatment. Traditional therapy group Inclusion Criteria: 1. Diagnosis of amblyopia in one or both eyes; 2. Age between 3 ~ 12 years old; 3. Individuals who have received traditional treatment methods such as refractive correction and occlusion treatment.

Exclusion criteria

Exclusion criteria: Digital Therapy Group Exclusion Criteria: 1. History of previous ocular disease or ocular surgery; 2. Those who have a rapid eye growth rate in the first half year of baseline (as defined in the study measurement section); 3. Those who use optical therapy for myopia prevention and control within 1 year before baseline and during the follow-up period; 4. Those who have received amblyopia function training before baseline Traditional therapy group Exclusion Criteria: 1. History of previous ocular disease or ocular surgery; 2. Those who have a rapid eye growth rate within half a year before baseline (see the study measurement section for definition); 3. Those who use optical therapy for myopia prevention and control within 1 year before baseline and during the follow-up period; 4. Those who have received amblyopia function training before baseline.

Design outcomes

Primary

MeasureTime frame
Rapid Axial Elongation;

Secondary

MeasureTime frame
vision;

Countries

China

Contacts

Public ContactJinrong Li

The Zhongshan Ophthalmic Center,Sun Yat-sen University

lijinrong@gzzoc.com+86 137 6331 2661

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026